| Literature DB >> 33304338 |
Natalia Carrillo Gaeta1, Emily Bean2,3, Asha Marie Miles2, Daniel Ubriaco Oliveira Gonçalves de Carvalho1, Mario Augusto Reyes Alemán1, Jeferson Silva Carvalho1, Lilian Gregory1, Erika Ganda2.
Abstract
The use of heavy metals in economic and social development can create an accumulation of toxic waste in the environment. High concentrations of heavy metals can damage human and animal health, lead to the development of antibiotic resistance, and possibly change in bovine microbiota. It is important to investigate the influence of heavy metals in food systems to determine potential harmful effects environmental heavy metal contamination on human health. Because of a mining dam rupture, 43 million cubic meters of iron ore waste flowed into the Doce river basin surrounding Mariana City, Brazil, in 2015. Following this environmental disaster, we investigated the consequences of long-term exposure to contaminated drinking water on the microbiome and resistome of dairy cattle. We identified bacterial antimicrobial resistance (AMR) genes in the feces, rumen fluid, and nasopharynx of 16 dairy cattle 4 years after the environmental disaster. Cattle had been continuously exposed to heavy metal contaminated water until sample collection (A) and compared them to analogous samples from 16 dairy cattle in an unaffected farm, 356 km away (B). The microbiome and resistome of farm A and farm B differed in many aspects. The distribution of genes present in the cattle's nasopharynx, rumen, and feces conferring AMR was highly heterogeneous, and most genes were present in only a few samples. The relative abundance and prevalence (presence/absence) of AMR genes were higher in farm A than in farm B. Samples from farm A had a higher prevalence (presence) of genes conferring resistance to multiple drugs, metals, biocides, and multi-compound resistance. Fecal samples had a higher relative abundance of AMR genes, followed by rumen fluid samples, and the nasopharynx had the lowest relative abundance of AMR genes detected. Metagenome functional annotation suggested that selective pressures of heavy metal exposure potentially skewed pathway diversity toward fewer, more specialized functions. This is the first study that evaluates the consequences of a Brazilian environmental accident with mining ore dam failure in the microbiome of dairy cows. Our findings suggest that the long-term persistence of heavy metals in the environment may result in differences in the microbiota and enrichment of antimicrobial-resistant bacteria. Our results also suggest that AMR genes are most readily detected in fecal samples compared to rumen and nasopharyngeal samples which had relatively lower bacterial read counts. Since heavy metal contamination has an effect on the animal microbiome, environmental management is warranted to protect the food system from hazardous consequences.Entities:
Keywords: antimicrobial resistance; dairy cattle; heavy metals; metagenomics; microbiome; shotgun sequencing
Year: 2020 PMID: 33304338 PMCID: PMC7701293 DOI: 10.3389/fmicb.2020.590325
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Hierarchy of antimicrobial resistance genes. Each gene or operon (“Group” level) belongs to a Mechanism, a Class, and a Type. Pairwise comparisons between farms and anatomical sites were made between Types, Classes, Mechanisms, and Groups to determine resistome differences.
Descriptive data on total sequences and base pairs, high quality sequences and average length sequences.
| Total sequences | 1,618,872,761 | 1,623,606,104 | 1,665,839,299 |
| Total base pairs | 305,622,131,406 | 289,694,665,004 | 313,199,561,929 |
| High quality sequences | 40,202,077 | 45,029,282 | 1,550,130 |
| Average length (bp) | 182 | 178 | 174 |
FIGURE 2Relative abundance of phyla and genera across farms and sites. Heat maps showing the relative abundance of most abundant phyla (A) and genera (B) determined on farm A and farm B in fecal swab, rumen fluid and deep nasopharyngeal swab of dairy cattle.
FIGURE 3Distribution of most abundant phyla and genera reveals differences across farms in each site. Bar plots showing the relative abundance of most abundant phyla (left) and genera (right) and differences between farm A (dark blue) and farm B (light blue) in (A) fecal swab, (B) rumen fluid, and (C) deep nasopharyngeal swab of dairy cattle. Pairwise comparisons were made between farms with Wilcox Sum test and different letters denote differences between farms (P < 0.05) within each taxa.
FIGURE 4Resistance classes are more prevalent in Farm A than Farm B. Average (per-sample) gene presence is shown within each farm across four resistance classes. Pairwise comparisons were made between farms with Kruskal–Wallis and asterisks denote differences between farms (P < 0.05) within each class.
FIGURE 5AMR gene distribution across farms and anatomical sites. UpSet plot of AMR gene distribution in each farm and anatomical site. Of the 549 AMR genes detected, 67 are found only in farm A fecal samples and 59 are only in farm A rumen fluid samples. The intersections of gene combinations are shown in the dot matrix and vertical bar plot. The set size (number of genes in each set) is shown in the horizontal gray bar plot. Most genes were detected in fecal and rumen fluid samples compared to DNS samples.
Median number of unique functions identified per metagenome, by farm and sampling site [feces, rumen fluid, or nasopharyngeal swab (DNS)].
| Farm A | 765.50 | 152.25 | 693.50 | 101.50 | 109.50 | 127.50 |
| Farm B | 922.00 | 154.50 | 703.00 | 208.00 | 164.00 | 391.50 |
FIGURE 6Heat map of the top 10 ECs selected by how well they distinguish (A) farm, (B) body site, and (C) farm given body site. Each box represents an individual sample and is shaded by its normalized read count value. Samples are stratified by farm (A,B) and body site from which the sample was taken [feces, rumen fluid, and deep nasal swab (DNS)]. ECs (Number: Class) = (A) 2.7.7.7: Nucleotidyltransferase, 2.7.7.8: Nucleotidyltransferase, 2.8.4.3: Methylsulfanyl transferase, 2.5.1.7: Alkyltransferase, 2.1.1.74: Methyltransferase, 2.4.2.14: Pentosyltransferase, 6.3.5.5: Carbon-nitrogen ligase, 1.1.1.49: Oxidoreductase, 3.1.3.16: Phosphoric - monoester hydrolase, 2.3.1.191: Acyltransferase. (B) 5.4.2.11: Phosphotransferase, 2.5.1.47: Alkyltransferase, 3.1.1.73: Carboxylic-ester hydrolase, 1.1.1.271: Oxidoreductase, 5.1.3.11: Epimerase, 1.1 1.1.22: Peroxidase, 1.1.1.192: Oxidoreductase, 4.2.1.45: Lyase, 3.2.1.80: Glycosylase, 1.5.1.43: Oxidoreductase. (C) 6.5.1.2: DNA ligase, 1.4.7.1: Oxidoreductase, 6.3.5.4: Carbon-Nitrogen Iigase, 4.2.2.23: Carbon-oxygen lyase, 2.7.1.162: Phosphotransferase, 3.4.21.1 16: Peptide hydrolase, 3.1.1.96: Carboxylic-ester hydrolase, 3.6.1.27: Nydr6lase, 3.2.1.156: Oiigosaccharide reducing-end xylanase, 1.5.1.43: Oxidoreductase.
Summary of informative E.C.s identified by the information gained with respect to “farm.”
| 1.1.1.49 | Oxidoreductase | Pentose phosphate; Glutathione metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments | 0 | 5.9 |
| 2.7.7.7 | Nucleotidyltransferase | 797 | 1010 | |
| 2.8.4.3 | Methylsulfanyl transferase | 343.5 | 403 | |
| 6.3.5.5 | Carbon-nitrogen ligase | Pyrimidine metabolism; Alanine, aspartate, and glutamate metabolism; Metabolic pathways | 167.9 | 123.2 |
| 2.5.1.7 | Alkyltransferase | Amino sugar and nucleotide sugar metabolism; Peptidoglycan biosynthesis; Metabolic pathways | 289.2 | 413.6 |
| 2.1.1.74 | Methyltransferase | 222.5 | 253 | |
| 3.1.3.16 | Phosphoric-monoester hydrolase | T cell receptor signaling; PD-L1 expression and PD-1 checkpoint pathway in cancer; Th1&Th2 cell differentiation | 3.4 | 6.5 |
| 2.3.1.191 | Acyltransferase | Lipopolysaccharide biosynthesis; Metabolic pathways | 6.6 | 6.5 |
| 2.7.7.8 | Nucleotidyltransferase | 867.5 | 1065.4 | |
| 2.4.2.14 | Pentosyltransferase | Purine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites | 199.1 | 202.4 |
Summary of informative E.C.s identified by the information gained with respect to “Site.”
| 1.5.1.43 | Oxidoreductase | Arginine and proline metabolism; Metabolic pathways | 17.4 | 60.7 | 0 |
| 3.1.1.73 | Carboxylic-ester hydrolase | 46.7 | 717.5 | 0 | |
| 1.1.1.271 | Oxidoreductase | Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways | 104.9 | 265.2 | 0 |
| 5.4.2.11 | Phosphotransferase | Glycolysis/Gluconeogenesis; Glycine, serine, and threonine metabolism; Methane metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments | 33.1 | 287.7 | 247109 |
| 5.1.3.11 | Epimerase | 45.5 | 190.6 | 0 | |
| 1.1.1.192 | Oxidoreductase | Fatty acid degradation | 53.9 | 120.8 | 0 |
| 3.2.1.80 | Glycosylase | Fructose and mannose metabolism | 18.2 | 84.9 | 0 |
| 2.5.1.47 | Alkyltransferase | Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments | 652.1 | 1104.1 | 0 |
| 4.2.1.45 | Lyase | Amino sugar and nucleotide sugar metabolism; Metabolic pathways | 31.7 | 92.1 | 0 |
| 1.11.1.22 | Peroxidase | 15.8 | 180 | 0 |
Summary of informative E.C.s identified by the information gained with respect to a compound “farm and Site” variable.
| 1.4.7.1 | Oxidoreductase | Glyoxylate and dicarboxylate metabolism; Nitrogen metabolism; Microbial metabolism in diverse environments | 214.9 | 770.2 | 0 | 123.3 | 744.2 | 377.4 |
| 6.5.1.2 | DNA ligase | 529.4 | 363.9 | 0 | 613.2 | 348.5 | 327.1 | |
| 6.3.5.4 | Carbon-Nitrogen ligase | Alanine, aspartate, and glutamate metabolism; Metabolic pathways, Biosynthesis of secondary metabolites | 85.4 | 452.3 | 0 | 21.33 | 524.4 | 0 |
| 3.6.1.27 | Hydrolase | Peptidoglycan biosynthesis | 81.3 | 34.5 | 0 | 73.8 | 32.4 | 0 |
| 2.7.1.162 | Phosphotransferase | 145.3 | 51.4 | 0 | 178.1 | 24.8 | 0 | |
| 4.2.2.23 | Carbon-oxygen lyase | 22.1 | 300.2 | 0 | 52.8 | 303.6 | 0 | |
| 3.2.1.156 | Oligosaccharide reducing-end xylanase | 17.0 | 89.5 | 0 | 233.0 | 69.4 | 0 | |
| 3.4.21.116 | Peptide hydrolase | 135.7 | 23.9 | 0 | 160.6 | 23.4 | 0 | |
| 1.5.1.43 | Oxidoreductase | Arginine and proline metabolism; Metabolic pathways | 18.0 | 56.1 | 0. | 13.6 | 66.3 | 0 |
| 3.1.1.96 | Carboxylic-ester hydrolase | 89.4 | 71.4 | 0 | 100.5 | 54.7 | 0 | |